Study Shows Nerandomilast Slowed Lung Function Decline in Progressive Pulmonary Fibrosis

Nerandomilast (BI 1015550) is an investigational oral drug that selectively inhibits phosphodiesterase 4B, exhibiting antifibrotic and…

Doc Medicare